2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO37] Mini-Oral Session 37　Cross-sectional Program 3（Clinical practice of immuno-check point inhibitor）
【E】

Sat. Feb 19, 2022 8:20 AM - 9:10 AM Room 7 (Room E, 1F, Kyoto International Conference Center)

Chair：Yasumasa Nishimura（Department of Radiation Oncology, Kindai University），Masato Masuda（Cancer Centre, University of the Ryukyus Hospital）

[MO37-6] Clinical safety of nivolumab 480 mg once every 4 weeks

○Taisuke Hosokai, Motoo Nomura, Masashi Tamaoki, Yosuke Mitani, Kenshiro Hirohashi, Masahiro Yoshioka, Taro Funakoshi, Akira Yokoyama, Junichi Matsubara, Yukiko Mori, Atsushi Yamada, Masashi Kanai, Reiko Kimura, Shigemi Matsumoto, Manabu Muto (Department of Medical Oncology, Hospital Kyoto University)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password